Celltrion Mulling Building New Plant in Asia - (The Korea Bizwire via NewsPoints Desk)

  • Celltrion is considering the construction of a new manufacturing facility in Asia in an effort to boost capacity and revenue, The Korea Bizwire reported Friday.

  • "I will prioritise a country where Celltrion can have 100 percent stake in the plant to prevent technology leaks," remarked CEO Seo Jeong-jin.

  • The drugmaker plans to select a site by June, which comes as the drugmaker is aiming to triple its production capacity to 360 000 litres.

  • Celltrion separately revealed that its revenue last year jumped 41.5 percent to 949 billion Korean won, while net profit surged 122 percent to 400.7 billion won.

  • Seo also revealed a plan to become one of the top three biotech firms globally by 2020.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.

Reference Articles